Free Trial

NeuroBo Pharmaceuticals (NRBO) Competitors

NeuroBo Pharmaceuticals logo
$1.04 -0.05 (-4.59%)
As of 10/16/2025

NRBO vs. OMCC, OCTO, KFFB, GREE, JFU, MDBH, CNF, BTOG, BCG, and JNVR

Should you be buying NeuroBo Pharmaceuticals stock or one of its competitors? The main competitors of NeuroBo Pharmaceuticals include Old Market Capital (OMCC), Eightco (OCTO), Kentucky First Federal Bancorp (KFFB), Greenidge Generation (GREE), 9F (JFU), MDB Capital (MDBH), CNFinance (CNF), Bit Origin (BTOG), Binah Capital Group (BCG), and Janover (JNVR). These companies are all part of the "banking" industry.

NeuroBo Pharmaceuticals vs. Its Competitors

Old Market Capital (NASDAQ:OMCC) and NeuroBo Pharmaceuticals (NASDAQ:NRBO) are both small-cap banking companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

Old Market Capital has higher revenue and earnings than NeuroBo Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Old Market Capital$9.37M3.85-$5.15M-$0.79-6.77
NeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/A

NeuroBo Pharmaceuticals has a net margin of 0.00% compared to Old Market Capital's net margin of -21.79%. Old Market Capital's return on equity of -7.01% beat NeuroBo Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Old Market Capital-21.79% -7.01% -4.78%
NeuroBo Pharmaceuticals N/A -189.12%-122.31%

39.9% of Old Market Capital shares are owned by institutional investors. Comparatively, 1.4% of NeuroBo Pharmaceuticals shares are owned by institutional investors. 50.4% of Old Market Capital shares are owned by company insiders. Comparatively, 1.1% of NeuroBo Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Old Market Capital
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NeuroBo Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Old Market Capital had 3 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 3 mentions for Old Market Capital and 0 mentions for NeuroBo Pharmaceuticals. Old Market Capital's average media sentiment score of 0.24 beat NeuroBo Pharmaceuticals' score of 0.00 indicating that Old Market Capital is being referred to more favorably in the media.

Company Overall Sentiment
Old Market Capital Neutral
NeuroBo Pharmaceuticals Neutral

Old Market Capital has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, NeuroBo Pharmaceuticals has a beta of -0.26, indicating that its stock price is 126% less volatile than the S&P 500.

Summary

Old Market Capital beats NeuroBo Pharmaceuticals on 10 of the 11 factors compared between the two stocks.

Get NeuroBo Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRBO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRBO vs. The Competition

MetricNeuroBo PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$8.96M$977.73M$6.10B$10.55B
Dividend YieldN/A4.84%5.73%4.78%
P/E RatioN/A1.2584.1027.14
Price / SalesN/A29.97607.17131.40
Price / CashN/A17.6437.8662.13
Price / Book0.698.0312.236.58
Net Income-$12.47M-$7.71M$3.32B$276.75M
7 Day Performance0.97%-0.52%0.74%0.93%
1 Month Performance-21.80%25.69%8.00%4.19%
1 Year Performance-67.09%-11.84%71.13%35.40%

NeuroBo Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRBO
NeuroBo Pharmaceuticals
N/A$1.04
-4.6%
N/A-63.2%$8.96MN/A0.0010High Trading Volume
OMCC
Old Market Capital
0.8948 of 5 stars
$5.08
+1.8%
N/A-13.1%$34.31M$13.09M-6.437News Coverage
Gap Down
OCTO
Eightco
N/A$11.07
+34.3%
N/A+288.1%$33.71M$43.87M0.0035
KFFB
Kentucky First Federal Bancorp
0.6049 of 5 stars
$4.11
+4.2%
N/A+13.0%$33.28M$19.74M205.8060Analyst Forecast
High Trading Volume
GREE
Greenidge Generation
N/A$2.12
-3.6%
N/A-25.3%$33.22M$59.53M0.00680Gap Down
High Trading Volume
JFU
9F
1.4982 of 5 stars
$2.71
flat
N/A+132.3%$31.91M$309.97M0.00740Analyst Forecast
Gap Down
MDBH
MDB Capital
3.1158 of 5 stars
$3.43
-2.1%
N/A-44.1%$31.85M$2.16M6.1240
CNF
CNFinance
2.0897 of 5 stars
$4.31
-10.2%
N/A-67.7%$29.56M$342.20M13.90900High Trading Volume
BTOG
Bit Origin
0.695 of 5 stars
$0.45
-9.8%
N/A-81.7%$26.60M$2.89M0.0010Analyst Forecast
Short Interest ↓
Gap Down
BCG
Binah Capital Group
0.4096 of 5 stars
$1.58
-7.6%
N/A-14.0%$26.23M$168.90M-13.17130Gap Up
JNVR
Janover
N/A$16.04
+1.6%
N/A+213.4%$25.34M$2.10M-6.2722High Trading Volume

Related Companies and Tools


This page (NASDAQ:NRBO) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners